per VivioMD's disclosures, these medical groups determine eligibility based on medical history, and the prescribing decision rests entirely with the evaluating clinician
yellow arrows represent cells with only Glp1r dots
The gut microbiota, through interactions with host cell receptors and metabolites produced, activate or inhibit signaling pathways, regulating many different aspects of metabolic diseases
The active molecule, dosing, and safety profile are identical
Being completely transparent about your health history allows your provider to create a safe and effective plan that accounts for your entire health profile and prevents unwanted complications
Studies conducted on patients with obesity and diabetes suggest that retatrutide may be better at zeroing in on fat, preserving more lean muscle mass than earlier generations of injectable GLP-1 drugs like Ozempic and Mounjaro